ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BIOL Biolase Inc

0.1461
0.0015 (1.04%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Biolase Inc NASDAQ:BIOL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0015 1.04% 0.1461 0.144 0.1484 0.1498 0.142 0.1446 569,226 00:58:25

BIOLASE, Inc to Report First Quarter 2021 Results on May 13, 2021

06/05/2021 9:05pm

PR Newswire (US)


Biolase (NASDAQ:BIOL)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Biolase Charts.

FOOTHILL RANCH, Calif., May 6, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2021 financial and operating results on Thursday, May 13, 2021 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.)

For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is (800) 353-6461. For international participants outside the U.S./Canada, the dial-in number is  (334) 323-0501. For all callers, refer to the Conference ID 5287389. To access the live webcast, go to BIOLASE Investor Events Page.

An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.

About BIOLASE
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-inc-to-report-first-quarter-2021-results-on-may-13-2021-301286021.html

SOURCE BIOLASE, Inc.

Copyright 2021 PR Newswire

1 Year Biolase Chart

1 Year Biolase Chart

1 Month Biolase Chart

1 Month Biolase Chart

Your Recent History

Delayed Upgrade Clock